Skip to main content

ScienceDex / Researcher record

Aisen, Paul S.

From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.

FY2021 NIH rank #37
  • Top 1% Funded
  • Rising Star
  • Sustained Excellence
  • R01 Holder
  • Long-Funded
  • Multi-Institutional

NIH Funding · FY2021

$34.7M
Full award amounts, FY2021
5
Records listing this PI
#37
By linked amount among FY2021 PIs
2001
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2001$532,7651#7,834
2002$464,4111#10,434
2003$385,1981#13,527
2015$2,210,5382#2,416
2016$5,949,1793#413
2017$1,758,0651#3,237
2018$7,467,5002#242
2019$13,977,4484#106
2020$24,533,8291#12
2021$34,707,4075#37
2022$26,095,7085#59
2023$11,248,9993#183

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20011 record
  2. FY20021 record
  3. FY20031 record
  4. FY20152 records
  5. FY20163 records
  6. FY20171 record
  7. FY20182 records
  8. FY20194 records
  9. FY20201 record
  10. FY2021 · selected5 records
  11. FY20225 records
  12. FY20233 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Aisen, Paul S.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2021 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2021 award records by amount

NIH award records listing Aisen, Paul S. as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG065248-02R01Contact PI
    Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months
    $14.6M
    award amount
  • 5R01AG058468-02R01Contact PI
    API A4 Alzheimer's Prevention Trial
    $7.2M
    award amount
  • 5R01AG063689-02R01Contact PI
    Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study
    $6.9M
    award amount
  • 5R01AG054029-03R01Contact PI
    The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease
    $4M
    award amount
  • 3R01AG047992-06S2R01Contact PI
    Long-Term Nicotine Treatment of Mild Cognitive Impairment - Bridge Funding
    $2M
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2001
    First NIH Award
    Cognition Therapeutics, Inc.
  2. 2001
    $500K Cumulative Funding
  3. 2001
    Entered Top 50% Nationally
    Ranked #7834
  4. 2002
    Multi-Institutional Research
    Awards at 4 institutions
  5. 2003
    $1M Cumulative Funding
  6. 2015
    $2M Cumulative Funding
  7. 2015
    Entered Top 25% Nationally
    Ranked #2416
  8. 2016
    $5M Cumulative Funding
  9. 2016
    Entered Top 10% Nationally
    Ranked #413
  10. 2016
    Entered Top 5% Nationally
    Ranked #413
  11. 2016
    R01 Grant Holder
  12. 2017
    $10M Cumulative Funding
  13. 2019
    $25M Cumulative Funding
  14. 2019
    Entered Top 1% Nationally
    Ranked #106
  15. 2020
    $50M Cumulative Funding
  16. 2022
    $100M Cumulative Funding